Abstract
ObjectiveUltra-small superparamagnetic iron oxide nanoparticles (USPIO) are promising contrast agents for magnetic resonance imaging (MRI). USPIO mediated proton relaxation rate enhancement is strongly dependent on compartmentalization of the agent and can vary depending on their intracellular or extracellular location in the tumor microenvironment. We compared the T1- and T2-enhancement pattern of intracellular and extracellular USPIO in mouse models of cancer and pilot data from patients. A better understanding of these MR signal effects will enable non-invasive characterizations of the composition of the tumor microenvironment.Materials and MethodsSix 4T1 and six MMTV-PyMT mammary tumors were grown in mice and imaged with ferumoxytol-enhanced MRI. R1 relaxation rates were calculated for different tumor types and different tumor areas and compared with histology. The transendothelial leakage rate of ferumoxytol was obtained by our measured relaxivity of ferumoxytol and compared between different tumor types, using a t-test. Additionally, 3 patients with malignant sarcomas were imaged with ferumoxytol-enhanced MRI. T1- and T2-enhancement patterns were compared with histopathology in a descriptive manner as a proof of concept for clinical translation of our observations.Results4T1 tumors showed central areas of high signal on T1 and low signal on T2 weighted MR images, which corresponded to extracellular nanoparticles in a necrotic core on histopathology. MMTV-PyMT tumors showed little change on T1 but decreased signal on T2 weighted images, which correlated to compartmentalized nanoparticles in tumor associated macrophages. Only 4T1 tumors demonstrated significantly increased R1 relaxation rates of the tumor core compared to the tumor periphery (p<0.001). Transendothelial USPIO leakage was significantly higher for 4T1 tumors (3.4±0.9x10-3 mL/min/100cm3) compared to MMTV-PyMT tumors (1.0±0.9x10-3 mL/min/100 cm3). Likewise, ferumoxytol imaging in patients showed similar findings with high T1 signal in areas of tumor necrosis and low signal in areas of intracellularly compartmentalized iron.ConclusionDifferential T1- and T2-enhancement patterns of USPIO in tumors enable conclusions about their intracellular and extracellular location. This information can be used to characterize the composition of the tumor microenvironment.
Highlights
Ultra small superparamagnetic iron oxide nanoparticles (USPIO) have been developed as contrast agents for magnetic resonance (MR) imaging [1,2,3,4,5]
4T1 tumors showed central areas of high signal on T1 and low signal on T2 weighted MR images, which corresponded to extracellular nanoparticles in a necrotic core on histopathology
As a proof-of-concept for clinical translation of the observed findings, we investigated four patients with bone tumors with ferumoxytol-enhanced magnetic resonance imaging (MRI) as a part of a larger clinical trial aimed at improving tumor staging with iron oxide based contrast agents [35]
Summary
Ultra small superparamagnetic iron oxide nanoparticles (USPIO) have been developed as contrast agents for magnetic resonance (MR) imaging [1,2,3,4,5]. USPIO have several advantages over standard small molecular paramagnetic contrast agents. Higher relaxivity (magnetic moment) leading to higher sensitivity [6]. 2. Specific tumor delivery via the enhanced permeability and retention (EPR) effect [7]. 3. Possibility to chemically link diagnostic pharmacophores for targeted delivery [8]. 4. Possibility to add other contrastophores for multi-modality imaging [9, 10]
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have